Preclinical Research Licenses. On a Collaboration Program-by-Collaboration Program basis, during the applicable Preclinical Research Term, subject to the terms and conditions of this Agreement, Regeneron hereby grants and shall grant to CytomX a non-exclusive, worldwide, royalty-free license under the Regeneron IP solely as necessary for CytomX to conduct the Preclinical Research set forth in each Work Plan under this Agreement during the Program Selection Period and the Product Selection Period. On a Collaboration Program-by-Collaboration Program basis, during the applicable Preclinical Research Term, subject to the terms and conditions of this Agreement, CytomX hereby grants and shall grant Regeneron a non-exclusive, royalty-free license under the CytomX IP that is necessary or reasonably useful for Regeneron to conduct the Preclinical Research and any other Regeneron obligations set forth in each Work Plan under this Agreement during the Term. For clarity, CytomX does not grant to Regeneron any rights under the Tools but CytomX will perform any research requiring the practice of such Tools itself under this Agreement.

Preclinical Research Licenses. On a Collaboration Program-by-Collaboration Program basis, during the applicable Preclinical Research Term, subjectLicense Grants to the terms and conditions of this Agreement, Regeneron hereby grants and shall grant to CytomX a non-exclusive, worldwide, royalty-free license under the Regeneron IP solely as necessary for CytomX to conduct the Preclinical Research set forth in each Work Plan under this Agreement during the Program Selection Period and the Product Selection Period. On a Collaboration Program-by-Collaboration Program basis, during the applicable Preclinical Research Term, subjectRegeneron. Subject to the terms and conditions of this Agreement, CytomX hereby grants and shall grant to Regeneron aan exclusive (even as to CytomX and its Affiliates, except as expressly set forth in this Agreement and subject to CytomX and its Affiliates retaining the non-exclusive,exclusive rights reasonably necessary or useful to perform CytomX’s obligations under this Agreement and any Work Plan) royalty-freebearing, sublicensable (but only in accordance with [Section 4.2]), license under the CytomX IP that is necessary or reasonably useful for Regeneron to conductExploit Licensed Products in the Preclinical Research and any other Regeneron obligations set forthLicensed Field in each Work Plan under this Agreementthe Territory during the Term. For clarity,Notwithstanding the foregoing, the CytomX doesKnow-How shall be sublicensable only in connection with the rights of Regeneron with respect to Products and not grantwith respect to Regeneron any rights underother products or services. Notwithstanding anything to the Tools but CytomX will perform any research requiring the practice of such Tools itself undercontrary in [Section 4.1.1] or elsewhere in this Agreement.Agreement, ​.